Blocking of CD56 with the anti-CD56 monoclonal antibody and knockdown of CD56 in CIK cells by short interfering RNA (siRNA) significantly reduced CIK-mediated lysis of three CD56+ hematopoietic tumor cell lines [19]. The gene discussed is NCAM1; the disease is neoplasm.